Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc.
In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs.
“I am thrilled to be taking on a more formal role at Obagi as the Company’s first-ever Chief Medical Director,” says Dr. Obagi in a news release. “Obagi has an incredible reputation for delivering high-quality, medical-grade skincare solutions. In this new position, I am looking forward to impacting upstream product development to deliver new innovations that solve more skin concerns for more patients and consumers, as well as educating the professional community on Obagi’s transformational, science-backed skincare solutions.”
“We are honored to deepen our relationship with Dr. Suzan Obagi as she assumes the role of Obagi’s inaugural Chief Medical Director,” adds Jordan Meyer, President of Obagi. “Dr. Obagi has been connected to our brand, in various capacities, since its inception. Her deep understanding of dermatology, commitment to patient care, and passion for advancing skincare reflect Obagi’s expertise and legacy in providing science-backed, physician-dispensed skincare solutions that empower individuals to achieve healthy, beautiful skin. We look forward to the positive impact her expertise will have on our team, products, and the overall skincare experience for our customers.”
